Myriad Genetics | MYGN - Market Capitalization


Myriad Genetics reported $284.9M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 44.23B 5.15B Aug/2026
Becton, Dickinson and Co. USD 51.35B 9.65B Aug/2026
Bio-Rad Laboratories USD 8.13B 263M Aug/2026
Bruker USD 8.3B 865M Aug/2026
Danaher USD 138.86B 10.4B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Quidel USD 1.09B 151M Aug/2026
Repligen USD 7.86B 168M Aug/2026
Revvity USD 14.32B 1.63B Aug/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Waters USD 24.41B 12.83B Aug/2026